Login to Your Account

Medivir Could Earn $111M Through New Tibotec Deals

By Cormac Sheridan

Thursday, July 6, 2006
Medivir AB could earn about $111 million in up-front and milestone payments from two new drug development licensing deals with Tibotec Pharmaceuticals Ltd. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription